STRATA Skin Sciences Inc (NASDAQ: SSKN) is having an overwhelmingly strong start to the trading session this morning after announcing the launch of the Nordlys device. As a result, investor excitement ensued and the stock started to push upward in a big way. Of course, our partners at Trade Ideas were the first to alert us to the gains. At the moment (9:31), SSKN is trading at $4.19 per share after a gain of $0.79 per share or 23.23% thus far today.
SSKS Gains On Nordlys Launch
As mentioned above, STRATA Skin Sciences is having a strong day in the market today after announcing the launch of he Nordlys device. SSKN is the exclusive United States destributor of the Nordlys laser, which is manufactured by Ellipse Global A/S. In a statement, Frank McCaney, CEO at SSKN had the following to offer…
“We are thrilled to launch the latest in non-ablative fractionated laser technology with the Nordlys device. Ellipse and STRATA have been working closely with globally renowned dermatologist Dr. Vic Ross to create the most advanced rejuvenation laser on the market. In a podium presentation at ASLMS, Dr. Ross demonstrated the uses and advantages of the Nordlys device, and presented the results of his study utilizing the Nordlys novel FRAX 1550 rolling fractional 1550nm laser on improving the effects of aging on facial skin.
“We expect that the system can become the device of choice for dermatologists and other physicians practicing in the aesthetic medicine field. We are forecasting sales of the device and accessories to be in the range of $4.0 to $4.5 million for 2017 which would contribute $500,000-600,000 in non-GAAP adjusted EBITDA.
The Nordlys system has 24 indications cleared to date by the FDA. It incorporates a multitude of light-based technologies all in one compact platform –SWT (Selective Waveband Technology: the latest evolution and most efficacious utilization of Intense Pulsed Light), Nd:YAG and the FRAX 1550 non-ablative fractionated technology. The Nordlys laser uses Ellipse’s patented Dual Wave Filtration, a technology that has made the Nordlys the device of choice to over 6,000 cosmetic and dermatologic physician offices worldwide.”
Stop wasting your time! Find winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will be keeping a close eye on SSKN. In particular, we’re looking forward to seeing the results of the launch of the Nordlys device. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!